← FDA Drug Approvals (Drugs@FDA)
TREZIX
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: KEY THERAP · Approved 2014-11-26
Drug application
- FDA Application #
ANDA204785- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TREZIX
- Generic name
- Acetaminophen
- Active ingredients
- ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- KEY THERAP
- First approval
- 2014-11-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown